Cannabis alleviates peripheral neuropathic pain in diabetes

July 25, 2015

Cannabis alleviates peripheral neuropathic pain in diabetes
A small trial shows a dose-dependent reduction in peripheral neuropathic pain in patients with diabetes, according to a study published in the July issue of The Journal of Pain.
(HealthDay)—A small trial shows a dose-dependent reduction in peripheral neuropathic pain in patients with diabetes, according to a study published in the July issue of The Journal of Pain.

Mark S. Wallace, M.D., from the University of California in San Diego, and colleagues conducted a randomized trial in 16 patients with painful . They examined the short-term efficacy and tolerability of inhaled cannabis; each participant was exposed to four single dosing sessions of placebo or to low, medium, or high doses of cannabis in a crossover design. The authors performed baseline spontaneous pain, evoked pain, and cognitive testing. Subjects were administered aerosolized or placebo and the pain intensity and subjective "highness" score was measured during the first hour and for an additional three hours.

The researchers found that spontaneous pain scores were significantly different between doses (P < 0.001). Comparisons between and low, medium, and high doses were significant (P = 0.031, 0.04, and < 0.001, respectively), as were those between high versus low and medium doses (both P < 0.001). The high dose had a significant effect on foam brush and von Frey evoked pain (P < 0.001). The high dose had a significant negative effect (impaired performance) on two of the three neuropsychological tests.

"This adds preliminary evidence to support further research on the efficacy of the cannabinoids in ," the authors write.

Explore further: Ketorolac doesn't reduce pain with IUD placement

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Ketorolac doesn't reduce pain with IUD placement

June 9, 2015
(HealthDay)—For patients undergoing intrauterine device (IUD) placement, ketorolac does not reduce pain with placement, but is associated with pain reduction at five and 15 minutes after placement, according to a study ...

Lidocaine patches don't cut pain after robotic cardiac valve sx

July 23, 2015
(HealthDay)—For patients undergoing robotic cardiac valve surgery, lidocaine 5 percent patches do not reduce acute or persistent pain, according to a study published online July 14 in Pain Medicine.

Botulinum toxin-A beneficial in painful diabetic neuropathy

April 3, 2015
(HealthDay)—Botulinum toxin-A (BTX-A) appears to be beneficial for painful diabetic neuropathy (PDN), according to a meta-analysis published online March 20 in Pain Medicine.

Exercise cuts pain interference from diabetic neuropathy

April 13, 2015
(HealthDay)—Aerobic exercise may help reduce perceived pain interference resulting from diabetic peripheral neuropathy (DPN), according to a brief research report published online March 20 in Pain Medicine.

Anxiety independently predicts pain in patients with MS

June 23, 2015
(HealthDay)—Pain is prevalent in more than half of patients with multiple sclerosis (MS), and is independently predicted by anxiety, according to a study published online June 18 in Pain Medicine.

Recommended for you

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.